Immix Biopharma (IMMX) Revenue & Revenue Breakdown
Immix Biopharma Revenue Highlights
Immix Biopharma Revenue by Period
Immix Biopharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -100.00% |
2022-12-31 | $-89.52M | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Immix Biopharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $4.78K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | -100.00% |
2022-12-31 | $-89.52M | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Immix Biopharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SONN | Sonnet BioTherapeutics | $147.81K | - |
CWBR | CohBar | - | - |
AVRO | AVROBIO | - | - |
CNSP | CNS Pharmaceuticals | - | - |
ELEV | Elevation Oncology | - | - |
ZVSA | ZyVersa Therapeutics | - | - |
OCEA | Ocean Biomedical | - | - |
IMMX | Immix Biopharma | - | - |
HEPA | Hepion Pharmaceuticals | - | - |
ENVB | Enveric Biosciences | - | - |
EFTR | eFFECTOR Therapeutics | - | - |
IMMX Revenue FAQ
What is Immix Biopharma’s yearly revenue?
Immix Biopharma's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $-89.517M, representing an increase of 100.00% compared to 2021. IMMX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Immix Biopharma’s quarterly revenue?
Immix Biopharma's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). IMMX's quarterly revenue for Q4 2023 was $4.78K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Immix Biopharma’s revenue growth rate?
Immix Biopharma's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.